获批FDA!强生旗舰PFA平台灌注流速更新

医疗器械创新网
16 Jul

2025年7月14日,强生医疗科技(Johnson & Johnson MedTech)宣布其VARIPULSE™平台针对灌注流速的最新优化已获美国食品药品监督管理局(FDA)批准。此举标志着强生在脉冲场消融(PFA)领域的又一里程碑,同时展现出其以数据为导向、贴近真实临床实践的技术创新策略。强生电生理与神经血管业务集团主席Michael Bodner表示:“我们从真实世界的经验中不断学习,并与...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10